<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15372/SSMJ20200610</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-523</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Факторы риска у больных неалкогольной жировой болезнью печени, ассоциированной с артериальной гипертензией, избыточной массой тела и ожирением</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors in patients with non-alcoholic fatty liver disease associated with arterial hypertension, overweight and obesity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаев</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaev</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юрий Алексеевич Николаев - доктор медицинских наук.</p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>Yuri A. Nikolaev - doctor of medical sciences.</p><p>630117, Novosibirsk, Timakov str., 2</p></bio><email xlink:type="simple">nicol@centercem.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севостьянова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevostyanova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгения Викторовна Севостьянова - кандидат медицинских наук.</p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>Evgenia V. Sevostyanova - candidate of medical sciences.</p><p>630117, Novosibirsk, Timakov str., 2</p></bio><email xlink:type="simple">luck.nsk@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поляков</surname><given-names>В. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakov</surname><given-names>V. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Яковлевич Поляков - доктор медицинских наук.</p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>Vladimir Ya. Polyakov - doctor of medical sciences.</p><p>630117, Novosibirsk, Timakov str., 2</p></bio><email xlink:type="simple">vpolyakov15@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митрофанов</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitrofanov</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Михайлович Митрофанов - доктор медицинских наук.</p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>Igor M. Mitrofanov - doctor of medical sciences.</p><p>630117, Novosibirsk, Timakov str., 2</p></bio><email xlink:type="simple">mim007@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ус</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Us</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алина Алексеевна Ус</p><p>630117, Новосибирск, ул. Тимакова, 2</p></bio><bio xml:lang="en"><p>Alina A. Us</p><p>630117, Novosibirsk, Timakov str., 2</p></bio><email xlink:type="simple">olimpiada2121@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФИЦ фундаментальной и трансляционной медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center for Fundamental and Translational Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2020</year></pub-date><volume>40</volume><issue>6</issue><fpage>99</fpage><lpage>105</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Николаев Ю.А., Севостьянова Е.В., Поляков В.Я., Митрофанов И.М., Ус А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Николаев Ю.А., Севостьянова Е.В., Поляков В.Я., Митрофанов И.М., Ус А.А.</copyright-holder><copyright-holder xml:lang="en">Nikolaev Y.A., Sevostyanova E.V., Polyakov V.Y., Mitrofanov I.M., Us A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/523">https://sibmed.elpub.ru/jour/article/view/523</self-uri><abstract><p>Цель исследования - изучить особенности встречаемости факторов риска у больных неалкогольной жировой болезнью печени, ассоциированной с артериальной гипертензией, избыточной массой тела и ожирением.</p><p>Материал и методы. Объектом исследования явились данные 14 393 историй болезней пациентов с артериальной гипертензией (АГ), неалкогольной жировой болезнью печени (НЖБП), избыточной массой тела (ИзМТ) и ожирением, проходивших обследование и лечение на базе клиники Федерального исследовательского центра фундаментальной и трансляционной медицины (г. Новосибирск).</p><p>Результаты и их обсуждение. Показано, что у больных с НЖБП, АГ, избыточной массой тела и ожирением статистически значимо больше, чем у пациентов с изолированными заболеваниями, транссистемная полиморбидность, систолическое и диастолическое артериальное давление, индекс массы тела, концентрация в сыворотке крови общего холестерина, триглицеридов, холестерина липопротеинов высокой плотности, глюкозы, мочевой кислоты, индекс атерогенности. Изучение частоты встречаемости факторов риска в группах показало у пациентов с ассоциированными заболеваниями наибольшие величины частоты повышенного артериального давления, дислипидемии, гипертриглицеридемии, гиперхолестеринемии, гипоальфахолестеринемии, гиперлипидемии, повышенного индекса атерогенности, гипергликемии, гиперурикемии, увеличения содержания С-реактивного белка, что указывает на наличие более выраженных изменений углеводного, липидного и пуринового обмена при данной сочетанной патологии. Эти изменения являются факторами утяжеления течения патологии и факторами риска развития сахарного диабета, атеросклероза и ассоциированных состояний, что требует персонифицированного подхода к лечению и профилактике данной категории больных. Результаты настоящего исследования могут быть положены в основу разработки новой медицинской технологии для оценки тяжести состояния больных НЖБП, сочетанной с АГ, избыточной массой тела и ожирением.</p></abstract><trans-abstract xml:lang="en"><p>Purpose of the study was to investigate the features of the occurrence of risk factors in patients with non-alcoholic fatty liver disease associated with arterial hypertension, overweight and obesity.</p><sec><title>Material and methods</title><p>Material and methods. The object of the study was the data of 14 393 case histories of patients with arterial hypertension (AH), non-alcoholic fatty liver disease (NFLD), overweight body (OB) and obesity, examined and treated at the clinic of the Federal Research Center forFundamental and Translational Medicine (Novosibirsk).</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Features of biochemical parameters in patients with NFLD with AH, OB and obesity were studied in comparison with patients with isolated diseases. It was shown that in patients, in case of the presence of this comorbidity, the value of transsystem polymorbidity is statistically significantly increased compared with groups of patients with isolated diseases. It was established that patients with concomitant diseases have higher, statistically significant values of systolic and diastolic blood pressure, body mass index. They have higher concentrations of total cholesterol, triglycerides, high density lipoprotein cholesterol, glucose, uric acid in the blood serum, higher atherogenic index. A study of the frequency of occurrence of risk factors in the groups showed the highest frequency values in patients with associated diseases: high blood pressure, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, hypoalphacholesterolemia, hyperlipidemia, increased atherogenic index, hyperglycemia, hyperuricemia, the higher levels of C-reactive protein, which indicates that with associated pathology, changes in carbohydrate, lipid and purine metabolism are more pronounced. These changes are factors that aggravate the course of the pathology and are risk factors for the development of diabetes mellitus, atherosclerosis and associated conditions, which requires a personalized approach to the treatment and prevention of this category of patients. The results of this study can form the basis for the development of new medical technology for assessing the severity of condition in patients with non-alcoholic fatty liver disease combined with arterial hypertension, overweight and obesity.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>неалкогольная жировая болезнь печени</kwd><kwd>артериальная гипертензия</kwd><kwd>избыточная масса тела</kwd><kwd>ожирение</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>non-alcoholic fatty liver disease</kwd><kwd>arterial hypertension</kwd><kwd>overweight</kwd><kwd>obesity</kwd><kwd>risk factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Белялов Ф.И. Лечение внутренних болезней в условиях коморбидности. Иркутск: РИО ИГМАПО, 2014. 308 с.</mixed-citation><mixed-citation xml:lang="en">Belyalov F.I. Treatment of internal diseases in conditions of comorbidity. Irkutsk, 2014. 308 р. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев Ю.А., Севостьянова Е.В., Митрофанов И.М., Поляков В.Я., Долгова Н.А. Особенности полиморбидности у пациентов терапевтической клиники кардиологического и гастроэнтерологического профиля. Терапевт. архив. 2016; 1: 40-45.</mixed-citation><mixed-citation xml:lang="en">Nikolaev Yu.A., Sevost’yanova E.V., Mitrofanov I.M., Polyakov V.Ya., Dolgova N.A. Features of polymorbidity in patients of the therapeutic clinic of cardiological and gastroenterological profiles. Tera-pevticheskiy arkhiv = Therapeutic Archive. 2016; 1: 40-45. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р.Г. Сосудистая коморбидность: общие подходы к профилактике и лечению. Рац. фармакотерапия в кардиологии. 2015; 11 (1): 4-7.</mixed-citation><mixed-citation xml:lang="en">Oganov R.G. Vascular comorbidity: general approaches to prevention and treatment. Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2015; 11 (1): 4-7. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Boyd C.M., Reider L., Frey K., Scharfstein D., Leff B., Wolff J., Groves C., Karm L., Wegene S., Marsteller J., Boul C. The effects of guided care on the perceived quality of health care for multi-morbid older persons: 18-month outcomes from a cluster-randomized controlled trial. J. Gen. Intern. Med. 2010; 25: 235-242. doi: 10.1007/s11606-009-1192-5</mixed-citation><mixed-citation xml:lang="en">Boyd C.M., Reider L., Frey K., Scharfstein D., Leff B., Wolff J., Groves C., Karm L., Wegene S., Marsteller J., Boul C. The effects of guided care on the perceived quality of health care for multi-morbid older persons: 18-month outcomes from a cluster-randomized controlled trial. J. Gen. Intern. Med. 2010; 25: 235-242. doi: 10.1007/s11606-009-1192-5</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев Ю.А., Геворгян М.М., Козарук Т.В., Кузнецова А.П., Поляков В.Я. Особенности клинико-биохимических и иммунологических показателей у больных артериальной гипертензией, пришлых жителей Севера, сочетанной с заболеваниями гепатобилиарной системы. Бюл. СО РАМН. 2012; 32 (4): 66-71.</mixed-citation><mixed-citation xml:lang="en">Nikolaev Yu.A., Gevorgyan M.M., Kozaruk T.V., Kuznetsova A.P., Polyakov V.Ya. Features of clinical-biochemical and immunological indices in patients with hypertension, alien residents of the North, combined with diseases of the hepatobiliary system. Byulleten’ Si-birskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk = Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2012; 32 (4): 66-71. [ In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Севостьянова Е.В., Николаев Ю.А., Митрофанов И.М., Поляков В.Я. Особенности полимор-бидности у больных артериальной гипертензией. Артериал. гипертензия. 2019; 25 (2): 200-208.</mixed-citation><mixed-citation xml:lang="en">Sevost’yanova E.V., Nikolaev Yu.A., Mitrofanov I.M., Polyakov V.Ya. Features of polymorbidity in patients with arterial hypertension. Arterial’naya gipertenziya = Arterial Hypertension. 2019; 25 (2): 200-208. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник Л.Б., Конев Ю.В., Ефремов Л.И. Основная проблема гериатрии - множественность болезней у пожилого больного. Клин. геронтология. 2019; 25 (1-2): 4-9.</mixed-citation><mixed-citation xml:lang="en">Lazebnik L.B., Konev Yu.V., Efremov L.I. The main problem of geriatrics is the multiplicity of diseases in an elderly patient. Klinicheskaya gerontologiya = Clinical Gerontology. 2019; 25 (1-2): 4-9. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Неалкогольная жировая болезнь печени и неалкогольный стеатогепатит. Глобальные практические рекомендации Всемирной гастроэнтерологической организации. Июнь 2012. Режим доступа: https://www.worldgastroenterology.org/UserFiles/file/guidelines/nafld-nash-russian-2012.pdf</mixed-citation><mixed-citation xml:lang="en">Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Global guidelines of the World gastroenterological organization. June 2012. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/nafld-nash-russian-2012.pdf [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F., Baigent C., Catapano A.L., Koski-nas K.C., Casula M., Badimon L. Chapman M.J., de Backer G.G., Delgado V., Ference B.A., Graham I.M., Halliday A., Landmesser U., Mihaylova B., Pedersen T.R., Riccardi G., Richter D.J., Sabatine M.S., Taskinen M.R., Tokgozoglu L., Wiklund O., ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020; 41 (1): 111-188. doi: 10.1093/eurheartj/ehz455</mixed-citation><mixed-citation xml:lang="en">Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L. Chapman M.J., de Backer G.G., Delgado V., Ference B.A., Graham I.M., Halliday A., Landmesser U., Mihaylova B., Pedersen T.R., Riccardi G., Richter D.J., Sabatine M.S., Taskinen M.R., Tokgozoglu L., Wiklund O., ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020; 41 (1): 111-188. doi: 10.1093/eurheartj/ehz455</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О.М., Яфарова А.А. Неалкогольная жировая болезнь печени и сердечно-сосудистый риск: состояние проблемы. Рац. фармакотерапия в кардиологии. 2017; 13 (5): 645-650.</mixed-citation><mixed-citation xml:lang="en">Drapkina O.M., Yafarova A.A. Non-alcoholic fatty liver disease and cardiovascular risk: state of the problem. Racional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2017; 13 (5): 645-650. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Черкашина Е.А., Петренко Л.В., Евстигнеева А.Ю. Неалкогольная жировая болезнь печени: патогенез, диагностика, лечение. Ульян. мед.-биол. журн. 2014; (1): 35-46.</mixed-citation><mixed-citation xml:lang="en">Cherkashina E.A., Petrenko L.V., Evstigneeva A. YU. Non-alcoholic fatty liver disease: pathogenesis, diagnosis, treatment. Ul’yanovskiy mediko-biologicheskiy zhurnal = Ulyanovsk Medico-Biological Journal. 2014; (1): 35-46. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Targher G., Marra F., Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia. 2008; 51 (11): 1947-1953. doi: 10.1007/s00125-008-1135-4</mixed-citation><mixed-citation xml:lang="en">Targher G., Marra F., Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia. 2008; 51 (11): 1947-1953. doi: 10.1007/s00125-008-1135-4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Драпкина О.М., Павлов Ч.С., Бакулин И.Г., Корнеева О.Н. Неалкогольный стеато-гепатит при метаболическом синдроме. Consilium medicum. 2007; (2): 18-21.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Drapkina O.M., Pavlov Ch.S., Bakulin I.G., Korneeva O.N. Non-alcoholic steatohepatitis in metabolic syndrome. Consilium Medicum. 2007; (2): 18-21. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Asrih M., Jornayvaz F.R. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol. Cell. Endocrinol. 2015; 418: 5565. doi: 10.1016/j.mce.2015.02.018</mixed-citation><mixed-citation xml:lang="en">Asrih M., Jornayvaz F.R. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol. Cell. Endocrinol. 2015; 418: 5565. doi: 10.1016/j.mce.2015.02.018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kanwar P., Kowdley K.V. The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clin. Liver Dis. 2016; 20 (2): 225-243. doi: 10.1016/j.cld.2015.10.002</mixed-citation><mixed-citation xml:lang="en">Kanwar P., Kowdley K.V. The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clin. Liver Dis. 2016; 20 (2): 225-243. doi: 10.1016/j.cld.2015.10.002</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Стаценко М.Е., Туркина С.В., Косивцова М.А., Тыщенко И.А. Неалкогольная жировая болезнь печени как мультисистемное заболевание. Вестн. ВолгГМУ. 2016; (2): 58-66.</mixed-citation><mixed-citation xml:lang="en">Stacenko M.E., Turkina S.V., Kosivcova M.A., Tyshchenko I.A. Non-alcoholic fatty liver disease as a multisystem disease. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta = Journal of the Volgograd State Medical University. 2016; (2): 58-66. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64 (1): 73-84. doi: 10.1002/hep.28431</mixed-citation><mixed-citation xml:lang="en">Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64 (1): 73-84. doi: 10.1002/hep.28431</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
